Latest Commercialisation News

EMVision is broadening its emu™ Pivotal Trial to include acute ischaemia detection, aiming to accelerate FDA clearance and enhance the brain scanner's clinical impact. Recruitment has passed 125 patients across US and Australian sites, with full enrolment expected by early 2027.

Elixir Energy has successfully completed stimulation and commenced flow testing at its Diona-1 well in Queensland’s Surat-Bowen Basin, with gas and condensate flowing at a notable pressure. The well’s proximity to existing pipeline infrastructure could facilitate rapid commercialisation if further testing confirms sustained production.

BCAL Diagnostics appoints Anne-Louise Arnett as CEO effective June 2026, aiming to accelerate its commercial rollout and international market entry of early cancer detection tests.

Adisyn’s subsidiary 2D Radar has teamed with Israeli plastics giant Raval to fast-track graphene-enhanced stealth parts for drones, aiming to compress development-to-production timelines from years to months.

Pure Resources has launched an integrated Defence Materials Platform Strategy for its Garnet Hills Project, leveraging US government collaborations to diversify from commodity mining into advanced defence supply chains.

Altech Batteries has decided to discontinue its Silumina AnodesTM project after six years, shifting full focus to its CERENERGY® solid-state battery technology amid ongoing joint venture talks.

Spenda Limited has sold its Ledger platform to APG Pay for $1.8 million, cutting $2.7 million in annual costs and streamlining operations to concentrate on its core revenue-generating products.

Aquirian Limited has secured $8 million through a strongly supported placement to accelerate growth of its Drillforce business and support a major $48 million contract at the Lord Byron mine.

Vectus Biosystems appoints Dr Tara Speranza as CEO and CTO to accelerate development of lead fibrosis drug VB0004 with performance-linked incentives.

BPH Global inks binding deal with Temasek Innovation Holdings to validate its seaweed-based male vitality product through targeted biological assays, advancing regulatory and commercial ambitions.

Green360 Technologies has successfully demonstrated its Eco-Clay product as a 50% Portland cement replacement in shotcrete applications, opening new avenues in underground and civil infrastructure markets.

NoviqTech (ASX: NVQ) advances its biochar carbon removal strategy with a key non-binding MoU covering 70% of credits from its Great Barrier Reef project, targeting 2026 commercial milestones.